79 FR 70 pgs. 20217-20218 - National Cancer Institute; Notice of Closed Meeting

Next Article Next

Type: NOTICEVolume: 79Number: 70Pages: 20217 - 20218

FR document: [FR Doc. 2014-08084 Filed 4-10-14; 8:45 am]

Agency: Health and Human Services Department

Sub Agency: National Institutes of Health

Official PDF Version: PDF Version

Pages: 20217, 20218

[top]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

[top] The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial

property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Cancer Institute Special Emphasis Panel Bridging the Gap from Cancer Mechanisms to Population Science.

Date: April 28, 2014.

Time: 4:00 p.m. to 5:00 p.m.

Agenda: To review and evaluate grant applications.

Place: National Cancer Institute Shady Grove, Room 7W264, 9609 Medical Center Drive, Rockville, MD 20850 (Telephone Conference Call).

Contact Person: Ellen K. Schwartz, EDD, MBA, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892-9750, 240-276-6384, schwarel@mail.nih.gov .

Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/advisory/irg/irg.htm, where an agenda and any additional information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: April 7, 2014.

David Clary,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2014-08084 Filed 4-10-14; 8:45 am]

BILLING CODE 4140-01-P